RIXATHON CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML
Product details
Registration number: SIN15970P
Classification: Prescription Only
Active ingredients: Rituximab
Strength: 100mg/10ml
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Registrant: SANDOZ SINGAPORE PTE. LTD.
ATC code: L01FA01
HSA approval date: 30 June 2020
Manufacturer(s):
- Lek Pharmaceuticals d.d. (Ljubljana)
- Novartis Pharmaceutical Manufacturing LLC (thawing and dispensing of drug substance)
Manufacturing country/countries: SLOVENIA
What are the HSA registration number and classification for RIXATHON CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15970P
Classification: Prescription Only
What active ingredients and strength are recorded for RIXATHON CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Rituximab
Strength: 100mg/10ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for RIXATHON CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Who is the recorded registrant for RIXATHON CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML?
According to the HSA dataset updated 7 August 2026:
Registrant: SANDOZ SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for RIXATHON CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Lek Pharmaceuticals d.d. (Ljubljana)
- Novartis Pharmaceutical Manufacturing LLC (thawing and dispensing of drug substance)
Manufacturing country/countries: SLOVENIA
Where can I look up RIXATHON CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15970P or the exact product name RIXATHON CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML. The general register link does not preselect this product.
What are the source dates for this RIXATHON CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this RIXATHON CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15970P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)